Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CapMan Plc 1–9 2024 Interim Report

CapMan PlcStock Exchange Release / Q3 Interim Report7 November 2024 at 8:00 a.m. EET CapMan Plc 1–9 2024 Interim Report Results for continuing operations and significant events in 1–9 2024: CapMan classifies CaPS business as a discontinued operation in the income statement and the comparison periods' figures are restated accordingly. · Assets under management EUR 6.0 billion 30 September 2024 (EUR 5.0 billion 31 December 2023). · Group turnover was MEUR 43.7 1 January–30 September 2024 (MEUR 37.9 1 January–30 September 2023). · Fee income was MEUR 39.9 (MEUR 34.9).

Clas Ohlson’s sales increased in October compared to the previous year

Net sales amounted to 972 MSEK (838), an increase by 16 per cent, of which 9 per cent relates to organic growth*, -2 per cent to currency effects and 8 per cent to sales in Spares Group. Compared with the same month of the preceding year, the store network increased by a net of 16 stores (reduction of 3 stores in the previous year). The total number of stores at the end of the period was 237.Total net sales for the period May-October 2024 amounted to 5,424 MSEK (4,653), an increase by 17 per cent compared with the corresponding period in the previous year, of which 9 per cent relates to

Clinical phase II trial of uPAR-PET in brain cancer patients published; data supports development of uTREAT for brain cancer

· Curasight’s radiopharmaceutical approach leverages the uPAR theranostic platform with the aim of providing improved diagnosis (uTRACE) and more gentle treatment (uTREAT) of certain types of cancers · Data from the Phase II uTRACE trial is now published in full in the peer-reviewed journal EJNMMI Research Copenhagen, Denmark, 7 November 2024 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) announces today that the investigator-initiated phase II study using uPAR-PET in brain cancer has been publishedThe investigator-initiated clinical trial testing [68]Ga-NOTA-AE105

New operating model implemented and cost measures deployed to drive improved profitability

Catena Media plc Interim Report January – September 2024 July-September 2024 · Revenue from continuing operations was EUR 10.7m (15.9), a decrease of 33 percent. · Revenue in North America decreased 29 percent to EUR 9.5m (13.3), equivalent to 89 percent (84) of group revenue from continuing operations. · New depositing customers (NDCs) from continuing operations totalled 27,342 (40,104), a decrease of 32 percent. · Adjusted EBITDA from continuing operations decreased 58 percent to EUR 1.3m (3.2), corresponding to an adjusted EBITDA margin of 13 percent (20). · EBITDA

Pihlajalinna Interim Report 1 January–30 September 2024: Solid development in organic growth and profitability

Pihlajalinna Plc                           Interim Report                            7 November 2024 at 8:00 a.m. Pihlajalinna Interim Report 1 January–30 September 2024 Solid development in organic growth and profitability This Interim Report is unaudited. The comparison figures in brackets refer to the corresponding period in the previous year. July–September in brief: · Revenue amounted to EUR 164.0 (165.6) million – a decrease of -1.0 per cent. · Comparable organic revenue growth[1)] was EUR 13.3 million, or 8.9 per cent. · In the Private Healthcare Services

Norconsult ASA: Q3 2024 - Solid growth and improved profitability

Sandvika, 7 November 2024 (OSE: NORCO): Income after external project costs increased with 13 percent compared to the third quarter last year. Organic growth adjusted for calendar effects was 11 percent. The adjusted EBITA margin adjusted for calendar effects was 8.6 percent in the quarter, up from 6.4 percent in the same quarter last year. Highlights Q3 2024 · Solid growth in income after external project costs of 13 percent to NOK 1 924 million (1 705) · Negative calendar effects of NOK 4 million · Organic growth of 11 percent adjusted for calendar effects · Adj. EBITA

INTERIM REPORT FOR THE THIRD QUARTER 2024 NEW WAVE GROUP AB

PERIOD 1 JULY – 30 SEPTEMBER 2024 · Net sales amounted to SEK 2,308.3 million, which was 1% lower than last year (SEK 2,337.0 million). Currency changes affected net sales negatively by 3%. · Operating result amounted to SEK 312.8 (381.1) million. · Result for the period amounted to SEK 204.1 (270.9) million. · Earnings per share amounted to SEK 1.54 (2.04). · Cash flow from operating activities amounted to SEK 191.4 (173.3) million. PERIOD 1 JANUARY – 30 SEPTEMBER 2024 · Net sales amounted to SEK 6,701.4 million, which was 1% lower than last year (SEK 6,777.0

Veidekke: Q3 2024 results

Veidekke achieved revenues of NOK 9.7 billion in Q3, and a pre-tax profit of NOK 616 million. The group’s order book totalled NOK 41 billion at quarter-end. The profit per share was NOK 3.4.“Veidekke has delivered a solid third-quarter performance. The margin on the project portfolio continues to rise, and is making up for reduced activity levels. As in earlier quarters of the year, Infrastructure Norway has delivered the greatest improvement,” says Group CEO Jimmy Bengtsson. “Our order book is strong, and the robust intake of both residential and commercial building orders indicates

Kojamo plc Interim Report 1 January–30 September 2024

Kojamo plc Stock Exchange Release, 7 November 2024 at 8.00 a.m. EETKojamo plc Interim Report 1 January–30 September 2024 Total revenue and net rental income increased, the fair value of investment properties remained unchanged This is a summary of the January–September Interim Report, which is in its entirety attached to this release and can be downloaded from the company’s website at www.kojamo.fi/investors. Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year. The figures in this Interim Report have not been audited.

Interim report Q3 2024

“In the third quarter, a seasonally weaker quarter for our three business areas, net sales reached SEK 7,991 million (8,333). Adjusted EBITA was SEK 783 million (725), with an adjusted EBITA margin of 9.8 percent (8.7). We continue to prioritise cash flow, organic profit growth and profitability, reflected in a cash conversion of 99 percent (LTM), improved profitability and marginally positive organic profit growth for the quarter”, says Christer Hansson, CEO of Storskogen.Third quarter (1 July - 30 September 2024) · Net sales decreased by 4 percent to SEK 7,991 million (8,333). ·

Camurus’ Interim Report Third Quarter 2024

“Solid third quarter and raised full-year outlook” Summary third quarter 2024 July - September · Total revenues amounted to SEK 480 (384) million. Excluding one-time revenues[1] of SEK 36 million in Q3 2023, company growth was 38% (41% at CER[2]). · Product sales of Buvidal[®] were SEK 421 (346) million, an increase of 22% (24% at CER[2]) and 5% (6% at CER[2]) compared to previous quarter · Brixadi[®] royalties were SEK 58 (1) million, an increase of 30% (39% at CER[2]) compared to previous quarter · Operating result was SEK 142 (104) million · Profit before tax was

Hexagon Composites ASA: Third quarter 2024

7 November 2024: Hexagon Composites (OSE: HEX.OL), world leader in composite cylinder technology and related systems for storage and transportation of clean gaseous energy reported revenues of NOK 1 250 million for third quarter 2024 (Q3’23: 1 148 million). The reported EBITDA was NOK 184 million (Q3’23: NOK 120 million), resulting in a 15% EBITDA margin (Q3’23: 10%). “Hexagon Group delivered a record-high EBITDA of NOK 184 million this quarter, thanks to significant operational efficiency improvements alongside increased heavy-duty truck activity in Hexagon Agility’s fuel systems

Strengthening of Asetek's financial position through rights issue and update of medium-term ambitions

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Aalborg, 7 November 2024 Strengthening of financial position through rights issue The board of directors of Asetek A/S ("Asetek" or the "Company") has resolved to seek to strengthen the Company's financial position through a rights issue. As announced in the half year report of 2024 of the Company and the related company announcement of 13 August

AutoStore: Q3 2024 financial results

Third quarter 2024 highlights (All comparisons to corresponding period in 2023) •          Order intake of USD 143.9 million, -5.1% YoY and on par QoQ •          Revenue of USD 144.2 million, slightly ahead of expectations communicated at recent Capital Markets Day •          2024 revenue guidance remains unchanged at USD 575-600 million •          Gross margin of 73.5%, +5.3 p.p. YoY and on par QoQ •          Consistent high adj. EBITDA margin of 46.8%, -0.6 p.p. YoY   (Nedre Vats, November 7, 2024): AutoStore Holdings Ltd. (AutoStore, OSE:AUTO), a robot technology

Noble Corporation plc publishes its quarterly report for the third quarter of 2024

SUGAR LAND, TEXAS, Nov. 6, 2024 /PRNewswire/ - With reference to the announcement published on November 5, 2024 containing the results of Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) for the quarterly period ended September 30, 2024, Noble hereby announces the publication of its quarterly report on Form 10-Q for the quarter ended September 30, 2024 (the "Quarterly Report").   The Quarterly Report has today been filed with the U.S. Securities and Exchange Commission and is available at https://bit.ly/3YAIwOc.   IMPORTANT INFORMATION This announcement is for

Lundin Mining Third Quarter 2024 Results

VANCOUVER, BC, Nov. 6, 2024 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) today reported its third quarter 2024 financial results. Unless otherwise stated, results are presented in United States dollars on a 100% basis. Jack Lundin, President and CEO commented, “Our overall performance has contributed to another near record quarter for revenue and copper production for the Company and we are on track to meeting full-year consolidated copper guidance. Operationally, Candelaria had an excellent third quarter producing 50,000 tonnes

Lundin Mining Announces Declaration of Regular Dividend

VANCOUVER, BC, Nov. 6, 2024 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of Canadian Dollars (“CAD”) $0.09 per share, payable on December 11, 2024, to shareholders of record at the close of business on November 29, 2024. The first day of trading without dividend (“ex-dividend date”) will be November 29, 2024, for shares traded on TSX. For shares traded on Nasdaq Stockholm, the ex-dividend date will be November 28, 2024. This dividend qualifies as

Borr Drilling Limited – Grant of Restricted Stock Units

Bermuda, November 6, 2024: The Board of Directors of Borr Drilling Limited (the "Company") (OSE and NYSE "BORR") informs that it has resolved to grant 136,612 Restricted Stock Units (each, a “RSU”) to its Directors. Each RSU represents one share in the Company. The RSUs will vest in full on September 30, 2025, and will be conditional on continuing to serve as a Director of the Company at the date of vesting. The RSUs will be settled through issuance of shares in the Company. Persons discharging managerial responsibilities (“PDMRs”), as defined by the (EU) Market Abuse Regulation, have

First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma

Oslo, Norway, November 6, 2024 - Lytix Biopharma, a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, announces that the first patient has been treated in a new Phase II trial (NeoLIPA). The study evaluates the effect of Lytix’s lead drug candidate, LTX-315, in early-stage patients diagnosed with melanoma. Melanoma is the most severe type of skin cancer with a rising incidence globally and an estimated global market of USD 11 billion by 2030.   “By expanding our clinical trials to early-stage melanoma patients we are adding to our robust

Borr Drilling Limited – Interim Financial Report on Form 6-K

Hamilton, Bermuda, November 6, 2024: Borr Drilling Limited (the “Company”) (OSE and NYSE: BORR) has today filed with U.S Securities and Exchange Commission its Unaudited Interim Financial Report for the three months and nine months ended September 30, 2024, on Form 6-K. The report is attached to this release and can also be found on the Company’s website www.borrdrilling.com and the U.S Securities and Exchange Commission website, www.sec.gov. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Borr Drilling Limited – Dividend declaration and key information relating to the cash distribution for the third quarter 2024

Hamilton, Bermuda, November 6, 2024. Borr Drilling Limited (NYSE and OSE: BORR) today announces that the Company’s Board of Directors has approved a cash distribution of paid-in capital of US$0.02 per share for the third quarter of 2024. Note to shareholders registered in Euronext VPS, the Norwegian Central Security Depository: Due to implementation of the Central Securities Depository Regulation (CSDR) in Norway, please note the information regarding the payment date for the shares registered in Euronext VPS below. Effective as of May 28, 2024, the New York Stock Exchange (“NYSE”)

Borr Drilling Limited Announces Third Quarter 2024 Results

Hamilton, Bermuda, November 6, 2024: Borr Drilling Limited (“Borr”, “Borr Drilling” or the “Company”) announces unaudited results for the three and nine months ended September 30, 2024. Highlights · Total operating revenues of $241.6 million, a decrease of $30.3 million or 11% compared to the second quarter of 2024 · Net income of $9.7 million, a decrease of $22.0 million or 69% compared to the second quarter of 2024 · Adjusted EBITDA of $115.5 million, a decrease of $20.9 million or 15% compared to the second quarter of 2024 · Year to date of report, the Company has

Nordea Bank Abp: Repurchase of own shares on 06.11.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares06.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 06.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |139,762|10.90 |1,523,741.

Mårten Frostne, CEO of FlexQube AB (publ), has decided to leave his role to pursue new challenges outside the company.

Mårten Frostne will remain in his position as CEO for up to six months or until his successor is in place. The Board thanks Mårten for his contributions during this time and will immediately begin the process of recruiting a successor.  About FlexQube FlexQube is a technology company headquartered in Gothenburg, Sweden with subsidiaries in USA, Mexico, Germany and England. FlexQube offers solutions for cart-based material handling using a patented modular concept. FlexQube develops and designs customized solutions for both robotic and mechanical cart logistics. Through the own

There are no items matching the current filter
There are no more items matching the current filter
Back to top